JP Morgan Private Wealth Advisors’s abrdn World Healthcare Fund THW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,004
Closed -$129K 2002
2022
Q3
$129K Sell
10,004
-3,901
-28% -$57.4K ﹤0.01% 1862
2022
Q2
$200K Hold
13,905
﹤0.01% 1827
2022
Q1
$212K Hold
13,905
﹤0.01% 1890
2021
Q4
$227K Hold
13,905
﹤0.01% 1861
2021
Q3
$229K Hold
13,905
﹤0.01% 1799
2021
Q2
$229K Buy
13,905
+929
+7% +$14.7K ﹤0.01% 1790
2021
Q1
$196K Hold
12,976
﹤0.01% 1698
2020
Q4
$205K Hold
12,976
﹤0.01% 1641
2020
Q3
$186K Hold
12,976
﹤0.01% 1528
2020
Q2
$186K Hold
12,976
﹤0.01% 1468
2020
Q1
$148K Hold
12,976
﹤0.01% 1337
2019
Q4
$180K Hold
12,976
﹤0.01% 1416
2019
Q3
$174K Buy
+12,976
New +$172K ﹤0.01% 1356
2019
Q1
Sell
-37,500
Closed -$435K 1511
2018
Q4
$435K Hold
37,500
﹤0.01% 1025
2018
Q3
$526K Hold
37,500
﹤0.01% 1056
2018
Q2
$483K Buy
+37,500
New +$485K ﹤0.01% 1018

Other funds holding THW

JP Morgan Private Wealth Advisors's THW Position: Q4 2022 in Review

JP Morgan Private Wealth Advisors sold out of abrdn World Healthcare Fund (THW) in Q4 2022, closing a stake of 10,004 shares — an estimated $129K sold.

JP Morgan Private Wealth Advisors first reported a position in THW in Q2 2018 and held it in 16 quarters. The position peaked at $526K in Q3 2018. 60 funds tracked by Wall St. Rank hold THW as of Q4 2022.

  • JP Morgan Private Wealth Advisors reported no remaining abrdn World Healthcare Fund position as of Q4 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 10,004 abrdn World Healthcare Fund shares in Q4 2022, an estimated $129K.
  • JP Morgan Private Wealth Advisors first reported a position in abrdn World Healthcare Fund in Q2 2018 and held it in 16 quarters.
  • JP Morgan Private Wealth Advisors's abrdn World Healthcare Fund position peaked at $526K in Q3 2018.
  • 60 funds tracked by Wall St. Rank held abrdn World Healthcare Fund as of Q4 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.